Pfizer Inc $29.28

down -0.11


2/9/2014 01:20 PM  |  NYSE : PFE  
Industries : Drugs / Drug Manufacturers - Major
Get Trend Analysis Icon Get PFE Trend Analysis - it has underperformed the S&P 500 by 18%

Partner Headlines

  1. Partnering With Big Pharma, Parexel Hits Its Stride

    IBD
  2. Amgen edges up on trial results

    IBD
  3. I Am Sure This Pharma-Company Suits Your Portfolio

    GuruFocus
  4. UPDATE: Protalix Shares Spike Higher on FDA Approval of Pediatric Indication ...

    Benzinga
  5. Higher Yielding Stocks With A Cheap EV/EBITDA Ratio And Low Debt Figures

    GuruFocus
  6. Fast Money Picks For August 28

    Benzinga
  7. Markets Little Changed In Low Volume And Slow News Ahead Of Long Weekend

    Benzinga
  8. Deutsche Bank Starts Pfizer, Lilly at Buy, Merck, Bristol-Myers at Hold

    Benzinga
  9. Deutsche Bank Says Pfizer Has A Strong Financial Position And Attractive ...

    Benzinga
  10. Benzinga's Top Initiations

    Benzinga
  11. Deutsche Bank Initiates Pfizer With Buy

    Benzinga
  12. Merck, Pfizer combining drugs

    IBD
  13. HCP Boosts Of 29 Years Of Dividend Increases

    IBD
  14. Economic Data Fuel Another All-Time High For S&P 500

    IBD
  15. Merck, Pfizer Combining Drugs In Lung Cancer Study

    IBD
  16. Pfizer, Merck Report Collaboration on Study Evaluating Novel Anti-Cancer ...

    Benzinga
  17. Late-Cycle Nirvana: Moaty Dividends on the Cheap

    YCharts
  18. 3 Pharma Companies That Could Deliver Breakthroughs In 'Plantibody' Technology

    Benzinga
  19. Nasdaq Leads Mixed Session; Actavis Extends Gains

    IBD
  20. Contract Researcher Parexel Sees Growth In Biotech

    IBD
  21. Illumina Forms Partnerships With Big Pharma Firms

    IBD
  22. Pfizer Could Revive AstraZeneca Bid As Early As Tuesday

    Benzinga
  23. Treasury Develolping Options to Curb Inversions

    FoxBusiness
  24. Guru Stocks at 52-Week Lows: PFE, GSK, VOD, EC, MFG

    GuruFocus
  25. Pfizer Announces Submission of Palbociclib New Drug Application To The ...

    Benzinga
  26. Pfizer Announces FDA Acceptance Of And Priority Review Designation For ...

    Benzinga
  27. Buyback ETF Slow-Footed: Better Ideas Here

    YCharts
  28. Buyback Mania Inflates 2Q Earnings Growth

    FoxBusiness
  29. YCharts Research: August 2014 Valuation Snapshot

    YCharts
  30. Pfizer Issues Top-Line Results from Potherpetic Neuralgia, Painful Diabetic ...

    Benzinga
  31. Earnings Season Is The Right Prescription For Health Care ETFs

    Benzinga
  32. Intercept Pharma Soars On Positive Liver Drug Data

    IBD
  33. Legendary Investor Irving Kahn's Top Five Stocks

    GuruFocus
  34. Novo Nordisk, Mylan Miss Views; Mallinckrodt Beats

    IBD
  35. Walgreen Leads Sell-Off In 'Tax Inversion' Stocks

    IBD
  36. Drugmaker AstraZeneca Returns To Growth

    IBD
  37. Widely Held Guru Stocks Near 52-Week Lows

    GuruFocus
  38. Pfizer To Buy Baxter's Vaccines For $635 Million: The Positives & Negatives

    Benzinga
  39. Walgreen Names New CFO Ahead of Possible Inversion

    IBD
  40. Guru Stocks at 52-Week Lows: PFE, GSK, VOD, EC, UBS

    GuruFocus
  41. The Stocks Already in Correction Mode

    FoxBusiness
  42. Will ImmunoGen's Q4 Earnings Disappoint Again?

    GuruFocus
  43. Stocks Mixed Despite Better-Than-Expected GDP

    Benzinga
  44. Amgen To Slash Workforce

    IBD
  45. Stocks Lower As Earnings Season Takes Back Seat To Geopolitical Uncertainties

    Benzinga
  46. Pharmaceutical ETFs Are Health Care Sector Standouts

    Benzinga
  47. Tuesday Morning Earnings Releases

    Benzinga
  48. Citigroup Comments On Potential Pfizer/AstraZeneca Acquisition

    Benzinga
  49. Merck, Pfizer Beat Q2 Earnings Estimates

    IBD
  50. Stocks Climb In Early Trade; Herbalife, El Pollo Loco Dive

    IBD
Trading Center